Novartis snaps up Selexys for sickle cell.
Chris
C
Morrison
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017322:Clinical Trials, Phase II as Topic; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C000614139:crizanlizumab